MedPath

Efficacy of Liposomal Bupivacaine for Prolonged Postoperative Analgesia in Patient Undergoing Breast Reconstruction With Tissue Expander

Phase 4
Completed
Conditions
Mammaplasty
Pain, Postoperative
Interventions
Registration Number
NCT04278846
Lead Sponsor
The Cleveland Clinic
Brief Summary

Patients undergoing breast reconstruction with tissue expanders will be treated with a local anesthetic during their procedure and monitor their post-operative pain level and amount of oral pain medication taken. This information will be used to determine if liposomal bupivacaine provides better and longer pain control vs. bupivacaine HCl.

Detailed Description

Fifty consecutive (25 per arm) patients undergoing unilateral or bilateral breast reconstruction with tissue expanders will be administered intraoperatively in a standardized manner with either bupivicaine HCl (control group) or liposomal bupivacaine/Exparel (experimental group). Pain will be assessed qualitatively through the use of: 1) numeric rating scale during rest (NRS-R) and activity (NRS-A), 2) brief pain inventory (BPI) questionnaire, and 3) postoperative analgesia patient satisfaction scale. Furthermore, investigators will record the use of rescue analgesics for each patient. This part of the study will provide quantitative data that investigators can then use in comparison to the qualitative measurements (NSR, BPI, patient satisfaction scale rate). In turn, this will allow us to objectify patient's pain, thereby increasing the validity of our results. More importantly, this aspect of the investigation will enable us to study the impact that liposomal bupivacaine has in reducing the postoperative usage of opioid medications in this patient population. As this is a pilot study, a sample size of 50 total patients (25 per treatment group) is planned. This sample size should provide estimates of potential effect sizes and variability in the present setting to allow for future study planning. This study should provide adequate evidence of whether pain decreases of 15% or more are unlikely in this setting.

Investigators aim to evaluate the effectiveness of DepoFoam Bupivicaine (Exparel®) to reduce postoperative pain in breast reconstruction patients compared to the current standard treatment (bupivacaine HCl). Investigators hypothesize that patients undergoing breast reconstruction with tissue expander will achieve greater control of post-operative pain and longer lasting analgesia with the use of liposomal bupivacaine.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
50
Inclusion Criteria
  • undergoing breast reconstruction with tissue expander
Exclusion Criteria
  • history of adverse reaction to local anesthesia
  • chronic liver disease
  • history of chronic preoperative consumption of narcotics or opioids
  • history of alcohol and/or illicit drug dependence
  • undergoing combined procedures
  • diagnosed with neuromuscular/neurosensory disorder
  • positive pregnancy test
  • previous breast conservation therapy (lumpectomy with radiation treatment
  • previous surgeries or trauma in the breast or chest region (denervation may bias pain perception)
  • axillary node dissection
  • psychosis.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
DepoFoam bupivacaineDepofoam bupivacainelocal anesthetic
Bupivacaine hydrochloride (HCl)Bupivacaine hydrochloride (HCl)local anesthetic
Primary Outcome Measures
NameTimeMethod
48 Hour Pain Assessment Numeric Rating Scale During Rest48 hours post-operatively

Pain will be assessed qualitatively through the use of numeric rating scale during rest (NRS-R).

The higher scores indicate more severe pain during rest (10 meaning the worst pain, 0 meaning no pain) The range is 0 to 10.

60 Hour Pain Assessment Numeric Rating Scale During Rest60 hours post-operatively

Pain will be assessed qualitatively through the use of numeric rating scale during rest (NRS-R).

The higher scores indicate more severe pain during rest (10 meaning the worst pain, 0 meaning no pain) The range is 0 to 10.

72 Hour Pain Assessment Numeric Rating Scale During Rest72 hours post-operatively

Pain will be assessed qualitatively through the use of numeric rating scale during rest (NRS-R).

The higher scores indicate more severe pain during rest (10 meaning the worst pain, 0 meaning no pain) The range is 0 to 10.

24 Hour Pain Assessment Numeric Rating Scale During Rest24 hours post-operatively

Pain will be assessed qualitatively through the use of numeric rating scale (0-10) during rest (NRS-R).

The higher scores indicate more severe pain during rest (10 meaning the worst pain, 0 meaning no pain)

36 Hour Pain Assessment Numeric Rating Scale During Rest36 hours post-operatively

Pain will be assessed qualitatively through the use of numeric rating scale (0-10) during rest (NRS-R).

The higher scores indicate more severe pain during rest (10 meaning the worst pain, 0 meaning no pain)

1 Hour Pain Assessment Numeric Rating Scale During Rest1 hour post-operatively

Pain will be assessed qualitatively through the use of numeric rating scale (0-10) during rest (NRS-R) Scale name: Numeric rating scale during rest (NRS-R) The higher scores indicate more severe pain during rest (10 meaning the worst pain, 0 meaning no pain)

8-12 Hour Pain Assessment Numeric Rating Scale During Rest8-12 hours post-operatively

Pain will be assessed qualitatively through the use of numeric rating scale (0-10) during rest (NRS-R) The higher scores indicate more severe pain during rest (10 meaning the worst pain, 0 meaning no pain)

84 Hour Pain Assessment Numeric Rating Scale During Rest84 hours post-operatively

Pain will be assessed qualitatively through the use of numeric rating scale (0-10) during rest (NRS-R).

The higher scores indicate more severe pain during rest (10 meaning the worst pain, 0 meaning no pain) The range is 0 to 10.

96 Hour Pain Assessment Numeric Rating Scale During Rest96 hours post-operatively

Pain will be assessed qualitatively through the use of numeric rating scale (0-10) during rest (NRS-R).

The higher scores indicate more severe pain during rest (10 meaning the worst pain, 0 meaning no pain) Range 0-10

36 Hour Pain Assessment Numeric Rating Scale During Activity36 hours post-operatively

Pain will be assessed qualitatively through the use of numeric rating scale (0-10) during activity (NRS-A).

The higher scores indicate more severe pain during activity (10 meaning the worst pain, 0 meaning no pain) The range is 0 to 10.

48 Hour Pain Assessment Numeric Rating Scale During Activity48 hours post-operatively

Pain will be assessed qualitatively through the use of numeric rating scale (0-10) during activity (NRS-A).

The higher scores indicate more severe pain during activity (10 meaning the worst pain,0 meaning no pain) The range is 0 to 10.

72 Hour Pain Assessment Brief Pain Inventory72 hours post-operatively

Pain will be assessed qualitatively through the use of the Brief Pain Inventory (BPI) Questionnaire This is also a validated scale from 0 to 10, with 10 having the most severe pain and 0 being no pain

60 Hour Pain Assessment Numeric Rating Scale During Activity60 hours post-operatively

Pain will be assessed qualitatively through the use of numeric rating scale (0-10) during activity (NRS-A).

The higher scores indicate more severe pain during activity (10 meaning the worst pain, 0 meaning no pain) The range is 0 to 10.

72 Hour Pain Assessment Numeric Rating Scale During Activity72 hours post-operatively

Pain will be assessed qualitatively through the use of numeric rating scale (0-10) during activity (NRS-A).

The higher scores indicate more severe pain during activity (10 meaning the worst pain, 0 meaning no pain) The range is 0 to 10.

84 Hour Pain Assessment Numeric Rating Scale During Activity84 hours post-operatively

Pain will be assessed qualitatively through the use of numeric rating scale (0-10) during activity (NRS-A).

The higher scores indicate more severe pain during activity (10 meaning the worst pain, 0 meaning no pain) The range is 0 to 10.

96 Hour Pain Assessment Numeric Rating Scale During Activity96 hours post-operatively

Pain will be assessed qualitatively through the use of numeric rating scale (0-10) during activity (NRS-A).

The higher scores indicate more severe pain during activity (10 meaning the worst pain, 0 meaning no pain) The range is 0 to 10.

96 Hour Pain Assessment Post-Operative Analgesia Patient Satisfaction96 hours post-operatively

Pain will be assessed qualitatively through the use of post-operative analgesia patient satisfaction scale (0-5) The higher scores indicate more satisfied patients.( 5 would be very satisfied-less pain, 0 would indicate unsatisfied patients-more pain)

48 Hour Pain Assessment Brief Pain Inventory48 hours post-operatively

Pain will be assessed qualitatively through the use of the Brief Pain Inventory (BPI) Questionnaire This is also a validated scale from 0 to 10, with 10 having the most severe pain and 0 being no pain

24 Hour Pain Assessment Brief Pain Inventory24 hours post-operatively

Pain will be assessed qualitatively through the use of the Brief Pain Inventory (BPI) Questionnaire This is also a validated scale from 0 to 10, with 10 having the most severe pain and 0 being no pain

96 Hour Pain Assessment Brief Pain Inventory96 hours post-operatively

Pain will be assessed qualitatively through the use of the Brief Pain Inventory (BPI) Questionnaire This is also a validated scale from 0 to 10, with 10 having the most severe pain and 0 being no pain

Secondary Outcome Measures
NameTimeMethod
24 Hour Use of Rescue Analgesic24 hours post operatively

We will record the amount in milligrams and type of rescue analgesic for each patient.

48 Hour Use of Rescue Analgesic48 hours post operatively

We will record the amount in milligrams and type of rescue analgesic for each patient.

72 Hour Use of Rescue Analgesic72 hours post operatively

We will record the amount in milligrams and type of rescue analgesic for each patient.

96 Hour Use of Rescue Analgesic96 hours post operatively

We will record the amount in milligrams and type of rescue analgesic for each patient.

Trial Locations

Locations (1)

Cleveland Clinic

🇺🇸

Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath